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434Objective: The objective of this study was to examine the incidence and clinical outcomes of residual lesions in
postoperative pediatric cardiac surgery patients receiving extracorporeal membrane oxygenation (ECMO)
support.
Methods: A retrospective observational study was undertaken at a pediatric heart institution. Postoperative
pediatric cardiac surgery patients receiving ECMO support within 7 days of surgery during the past 7 years
(2005-2011) were studied. A hemodynamically significant cardiac lesion on ECMO support that required inter-
vention to decannulate successfully was defined as a residual lesion. Demographic data, complexity of cardiac
defect, surgical data, indications for ECMO, echocardiographic findings, and cardiac catheterization results
were studied. Evaluation of residual lesions based on duration of ECMO support, interventions undertaken,
and clinical outcomes were also examined.
Results: Residual lesions were evaluated in 43 of 119 postoperative patients placed on ECMO support. Lesions
were detected in 35 patients (28%), predominantly in branch pulmonary arteries (n ¼ 10), shunts (n ¼ 7), and
ventricular outflow tracts (n ¼ 9). Echocardiography detected 7 residual lesions (20%) and cardiac catheteriza-
tion detected 28 residual lesions (80%). Earlier detection of residual lesions during the first 3 days of ECMO
support in 24 patients improved their rate of decannulation significantly (P ¼ .004) and survival to hospital
discharge (P ¼ .035), compared with later detection (after 3 days of ECMO support) in 11 patients.
Conclusions: Residual lesions are present in approximately one-quarter of postoperative cardiac surgery
patients requiring ECMO support. All postoperative pediatric cardiac surgery patients unable to be weaned
off ECMO successfully should be evaluated actively for residual lesions, preferably by cardiac catheterization
imaging. Earlier detection of residual lesions and reintervention are associated with improved clinical outcome.
(J Thorac Cardiovasc Surg 2014;147:434-41)The first application of extracorporeal membrane oxygena-
tion (ECMO) following palliative repair of congenital heart
disease in pediatrics was reported in 1970.1 The use of
ECMO in pediatric cardiac surgery has increased steadily
during the past 3 decades.2 The indications for ECMO sup-
port have broadened during this time to include low cardiac
output, failure towean from cardiopulmonary bypass, unex-
pected cardiac arrest, severe cyanosis, or refractory arrhyth-
mias.3 The increase in ECMO use has been associated
concomitantly with advances in oxygenator technology, en-
hanced coating material of the ECMO circuit internal sur-
face, improved anticoagulation strategies, and increasede Department of Pediatrics,a ECMO Division,b Department of Pediatrics, and
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The Journal of Thoracic and Cardiovascular Surgsophistication in blood flow controller use in the ECMO cir-
cuit.4 However, the mortality in pediatric cardiac surgery
patients requiring ECMO support continues to remain
high despite increased efficacy in ECMO circuits and post-
operative cardiac care.2,4
Extracorporeal membrane oxygenation is a support mo-
dality and not a treatment by itself. The primary aim of
ECMO support is to unload the heart and to decrease its
work to allow complete recovery of cardiac function from
surgery within a short period of time. Residual lesions in
cardiac surgery patients receiving ECMO support5-8 may
result in incomplete recovery of cardiac function. The
clinical decision to study residual lesions in patients on
ECMO support by means of echocardiography or cardiac
catheterization is quite subjective, and is based largely on
clinical judgment.5 Because there are few reports that
have evaluated residual lesions and their outcomes in pedi-
atric cardiac surgery patients placed on ECMO,5,9 the
primary aim of our study was to evaluate the incidence of
hemodynamically significant residual lesions that required
reintervention to separate successfully from ECMO
support. Our secondary aim was to study clinical
outcomes based on time period of residual lesion
detection on ECMO support.ery c January 2014
Abbreviations and Acronyms
ECMO ¼ extracorporeal membrane oxygenation
E-CPR ¼ extracorporeal cardiopulmonary
resuscitation
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This single-institution retrospective study was undertaken at the Pediat-
ric Heart Institute at theMonroeCarell Jr. Children’s Hospital at Vanderbilt.
The institution review board reviewed and approved the study protocol.
All consecutive postoperative pediatric (<18 years) cardiac surgery pa-
tients placed on ECMO between January 1, 2005, and December 31, 2011,
were included in our study. The postoperative period was defined as the
time interval from cardiac surgery to postoperative day 7.10 Demographic
data including age, weight, gender, primary cardiac defect, cardiac surgery
undertaken, cardiopulmonary bypass time, and crossclamp time were stud-
ied. The severity of underlying disease and the procedure performed were
assessed using the Risk Adjustment in Congenital Heart Surgery version 1
classification.11 Electronic medical records, echocardiographic findings,
cardiac catheterization reports, and operative reports were examined for
collection of our data.
Indications for ECMO support were subcategorized as failure to sepa-
rate from cardiopulmonary bypass, low cardiac output status despite max-
imal isotropic and ventilatory support, cardiac arrest with ECMO use for
cardiopulmonary resuscitation (extracorporeal cardiopulmonary resuscita-
tion [E-CPR]), and others, including respiratory failure, pulmonary hyper-
tension, or arrhythmias.3,7 The time interval from cardiac surgery to
placement on ECMO, duration of ECMO support, and the presence of
renal failure on ECMO as defined by a serum creatinine value
>1.5 mg/dL or the need for continuous renal replacement therapy on
ECMO were recorded. Weaning and separation from ECMO support was
based on either adequate cardiopulmonary stability, or the development
of one or more incidences of irreversible organ dysfunction precluding
survival. Any patient who was unable to tolerate successfully weaning of
ECMO flows or a clamping trial of the ECMO circuit without significant
escalation of inotropic support, volume resuscitation, and/or high
ventilator requirements was considered to have failed the weaning trial
of ECMO. Patients who failed the weaning trial of ECMO without
a clear cause were investigated for presence of residual lesions. Imaging
studies including transthoracic echocardiography and cardiac
catheterization were undertaken to evaluate residual lesions. A
transthoracic echocardiography imaging study was undertaken during the
weaning process of ECMO flows and was, in general, the initial imaging
study for evaluating residual lesions. A cardiac catheterization imaging
study was undertaken when the echocardiographic results were
inconclusive and patient was unable to be weaned off ECMO support
successfully. Any hemodynamically significant cardiac defect that
necessitated reintervention to separate successfully from ECMO was
defined as a residual lesion.5 The recognition of residual lesions based
on duration of ECMO support was evaluated. Residual lesions detected
during the first 3 days of ECMO were labeled as early diagnosis; residual
lesions detected after 3 days of ECMO support were labeled as late diagno-
sis. Decannulation from ECMO and survival to hospital discharge was
studied for all patients.
Continuous variables are presented as median values and interquartile
ranges, and categorical variables are presented as numbers and percentages
in the tables and the text. To compare data between groups, we used 2-sided
tests. The Wilcoxon rank sum test was used to compare continuous vari-
ables and Pearson’s c2 test was used to compare categorical variables.
Yates correction was applied when appropriate. A P value of .05 or less
was considered to be significant.The Journal of Thoracic and CaRESULTS
During the 7-year study period, 3447 pediatric patients
underwent cardiac surgery in our institution. One hundred
ninety-two patients of 3447 patients (5.5%) were placed
on ECMO for cardiac indications. One hundred nineteen
of 192 patients (62%) were placed on ECMO postopera-
tively within the first 7 days of surgery. Extracorporeal
membrane oxygenation during the postoperative period in
these 119 patients was performed by central cannulation
via the open chest.
The demographics, complexity of cardiac defect, cardiac
surgery details, and ECMO details are shown in Table 1. Of
the 119 postoperative patients placed on ECMO, 50 patients
(42%) were placed on ECMO coming off cardiopulmonary
bypass, 25 patients (21%) were placed on ECMO for low
cardiac output status in the intensive care unit with elevated
serum lactate levels and high inotrope and ventilator sup-
port, 34 patients (29%) were placed on ECMO for
E-CPR, and 10 patients (8%) were placed for other reasons,
including acute respiratory failure (n ¼ 5), pulmonary
hypertension (n ¼ 3), and refractory arrhythmias (n ¼ 2).
Thirty-four patients were placed on ECMO as E-CPR
with a mean duration of 33  15.6 minutes of conventional
cardiopulmonary resuscitation before placement on
ECMO. Seventy-five of 119 postoperative patients (63%)
placed on ECMO were decannulated successfully and 49
of these patients (41%) survived to hospital discharge.
Forty-three of the 119 patients were evaluated for resid-
ual lesions by imaging studies because they were unable
to be weaned successfully from ECMO support. Transtho-
racic echocardiographic imaging studies during the wean-
ing process of ECMO flows were undertaken in 40
patients and cardiac catheterization imaging was under-
taken in 36 patients to evaluate residual lesions. Transtho-
racic echocardiography identified residual lesions in 7 of
the 40 patients (17%) studied; cardiac catheterization iden-
tified residual lesions in 28 of the 36 patients (78%) that un-
derwent this study. Transthoracic echocardiography was
undertaken in 59 (78%) of the remaining 76 patients during
the course of ECMO support. Echocardiography, however,
was not done during the weaning process of ECMO flows
in these patients, and in none of these 59 patients were
any residual lesions detected. One of the remaining 76 pa-
tients underwent a cardiac catheterization study that re-
vealed elevated end diastolic pressures in the right ventricle.
Residual lesions requiring reintervention were detected
in 35 of the 43 patients (81%) studied. The 7 residual le-
sions detected by transthoracic echocardiography included
proximal branch pulmonary artery stenosis (n ¼ 3),
Blalock-Taussig shunt thrombosis (n¼ 2), patent ductus ar-
teriosus (n ¼ 1), and pulmonary overcirculation secondary
to a large Blalock-Taussig shunt (n ¼ 1). Transthoracic
echocardiography was the only imaging study undertakenrdiovascular Surgery c Volume 147, Number 1 435
TABLE 1. Demographic and ECMO details of postoperative patients
placed on ECMO within 7 days of surgery (n ¼ 119)
Variable Total (n = 119)
Age, days; mean (IQR) 12 (6-79)
Weight, kg; mean (IQR) 3.3 (2.7-4.1)
Gender, n (%)
Male 67 (56)
Female 52 (44)
Ventricle physiology, n (%)
One 58 (49)
Two 61 (51)
RACHS, category; n (%)
2 11 (9)
3 46 (38)
4 15 (13)
5-6 40 (34)
Could not be ranked 7 (6)
CPB, min; mean (IQR) 185 (128-282)
ECMO indication, n (%)*
1 50 (42)
2 25 (21)
3 34 (29)
4 10 (8)
ECMO location, n (%)
Operating room 58 (49)
ICU 61 (51)
Surgery-ECMO interval, days; mean (IQR) 0 (0-0)
ECMO duration, days; mean (IQR) 4 (2-7)
Renal failure, n (%) 41 (34)
Decannulation, n (%) 75 (63)
Survival to hospital discharge, n (%) 49 (41)
IQR, Interquartile range; RACHS, Risk Adjustment in Congenital Heart Surgery,
CPB, cardiopulmonary bypass; ECMO, Extracorporeal membrane oxygenation;
ICU, intensive care unit. *ECMO indication: 1, off CPB; 2, low cardiac output; 3, car-
diac arrest requiring cardiopulmonary resuscitation; 4, other, including respiratory
failure, pulmonary hypertension, and arrhythmias.
TABLE 2. Detection of residual lesions by echocardiography and/or
cardiac catheterization in postoperative cardiac surgery patients
placed on ECMO
Residual lesions n
Early detection (<3 d of ECMO support) 25*
Sano/Blalock-Taussig shunt stenosis/thrombosis 7
Aortic arch stenosis/thrombosis 6
Right ventricular outflow tract/main pulmonary artery gradient 3
Branch pulmonary artery stenosis/hypoplasia 3
Pulmonary overcirculation 2
Patent ductus arteriosus 1
Pulmonary vein stenosis 1
Tricuspid regurgitation 1
Aortic valve insufficiency 1
Late detection (>3 d of ECMO support) 13*
Branch pulmonary arteries stenosis/hypoplasia 7
Pulmonary vein stenosis 2
Right ventricular outflow tract/main pulmonary artery gradient 2
Mitral regurgitation 1
Aortopulmonary collateral 1
ECMO, Extracorporeal membrane oxygenation. *More than 1 residual lesion may
have been detected per patient studied.
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ual lesions detected by cardiac catheterization included
branch pulmonary arteries stenosis (n¼ 7), right ventricular
outflow tract stenosis (n ¼ 4), Blalock-Taussig or Sano
shunt stenosis (n ¼ 4), stenosis of aorta (n ¼ 4), pulmonary
vein stenosis (n ¼ 3), thrombus in aorta (n¼ 2), pulmonary
overcirculation (n ¼ 1), aortopulmonary collateral (n ¼ 1),
mitral valve regurgitation (n¼ 1), and tricuspid valve regur-
gitation (n¼ 1). Twenty-five of these 28 patients underwent
transthoracic echocardiography during the weaning process
of ECMO flows. There was some agreement of echocardio-
graphic findings with cardiac catheterization results in 3 of
these 25 patients for suspicion of residual lesions. Transtho-
racic echocardiography revealed moderate tricuspid regur-
gitation during the clamp trial of ECMO in 1 patient who
had severe tricuspid regurgitation on cardiac catheterization
that required reintervention, it revealed mild right ventricle-
to-pulmonary artery conduit stenosis in a second patient
who had severe distal conduit stenosis and proximal branch
pulmonary artery stenosis that required reintervention, and436 The Journal of Thoracic and Cardiovascular Surgit revealed decreased blood flow in bilateral branch pulmo-
nary arteries in the third patient who had diffuse branch pul-
monary artery hypoplasia that required reintervention.
Eight of the remaining 36 patients evaluated by cardiac
catheterization revealed severe diastolic dysfunction
(n ¼ 4), diffuse coronary artery thrombosis (n ¼ 2), and
no hemodynamically significant residual lesions (n ¼ 2).
The 2 patients in whom no residual lesions were detected
had respiratory causes for their deterioration: viral pneumo-
nia and multilobe atelectasis. All of these 8 patients under-
went a transthoracic echocardiography imaging study
during the weaning process of ECMO flow that was incon-
clusive. The types of residual lesions detected in our study
based on the time period of ECMO support are shown in
Table 2. Thirty-three of 43 patients (77%) evaluated for re-
sidual lesions on ECMO in our study underwent a transtho-
racic or epicardial echocardiographic study at the end of
their surgery.
Seven interventions for residual lesions were undertaken
in the cardiac catheterization laboratory, 27 in the operating
room, and 1 in the intensive care unit (Table 3). After the
hemodynamically significant residual lesions were identi-
fied, they were corrected within the next 24 hours. The
residual lesions that were identified in the cardiac catheter-
ization laboratory and that were amenable to intervention in
the laboratory were corrected at the time of the study, after
discussion with the surgeon and cardiology team. If the le-
sions required surgical intervention, they were corrected
within the next 24-hour period, depending on the earliest
availability of the surgeon. There were no major complica-
tions during and after cardiac catheterization on ECMO,
such as excessive blood loss requiring reexploration,ery c January 2014
TABLE 3. Interventions undertaken for residual lesions detected in
postoperative cardiac surgery patients placed on ECMO
Intervention undertaken n
Cardiac catheterization technique
Early detection (3 d of ECMO duration)
Sano shunt dilation 1
Balloon angioplasty of branch pulmonary arteries 1
Balloon septostomy of atrial septal defect 1
Angiojet and thrombolysis of clot in distal Blalock-Taussig
shunt and descending aorta
1
Late detection (>3 d of ECMO duration)
Stent placement in branch pulmonary artery 2
Balloon dilation of atrial septal defect 1
Surgical intervention*
Early detection (3 d of ECMO duration)
Sano/Blalock-Taussig shunt revision 4
Aortic arch revision 3
Branch pulmonary artery plasty 2
Right ventricular outflow tract/conduit revision 1
Ventricular septal defect revision 1
Patent ductus arteriosus ligation 1
Late detection (>3 d of ECMO duration)
Branch pulmonary artery plasty 3
Blalock-Taussig shunt addition/revision 3
Right ventricular outflow tract/conduit revision 2
Atrioventricular valve repair 2
Pulmonary vein stenosis repair 1
Aortopulmonary collateral ligation 1
ECMO, Extracorporeal membrane oxygenation. *More than 1 intervention may have
been performed per patient studied.
TABLE 4. Comparison of pediatric cardiac surgery patients on
ECMO support detected with and without residual lesions
Details
Patients with
residual lesions
(n ¼ 35)
Patients without
suspected
residual lesions
(n ¼ 84)
P
value
Age, days; mean (IQR) 10 (5-86) 13 (6-72.5) .74
Weight, kg; mean (IQR) 3.3 (2.7-4.1) 3.2 (2.8-4.1) .99
Gender, n (%)
Male 15 (43) 37 (44) 1.0
Female 20 (57) 47 (56) 1.0
Ventricle physiology, n (%)
One 20 (57) 38 (45) .31
Two 15 (43) 46 (55) .31
RACHS, category; n (%)
2 4 (11) 7 (8) .73
3 14 (40) 32 (38) .84
4 2 (6) 13 (16) .23
5-6 14 (40) 26 (31) .4
Could not be ranked 1 (3) 6 (7) .67
CPB, min; mean (IQR) 185 (130.5-290.5) 185.5 (127.7-270) .86
Xct, min; mean (IQR) 55 (30-87.5) 51 (27-75.2) .35
ECMO indication, n (%)*
1 11 (31) 39 (46) .15
2 12 (34) 13 (15) .03
3 9 (26) 25 (30) .82
4 3 (9) 7 (8) 1.0
Surgery-ECMO interval,
days; mean (IQR)
0 (0-1) 0 (0-0) .54
ECMO duration, days;
mean (IQR)
6 (4.5-10.5) 3 (2-6) <.001
Renal failure, n (%) 14 (40) 27 (32) .53
Decannulation, n (%) 25 (71) 50 (60) .3
Hospital discharge, n (%) 16 (46) 33 (39) .54
IQR, Interquartile range; RACHS, Risk Adjustment in Congenital Heart Surgery;
CPB, cardiopulmonary bypass; Xct, crossclamp time; ECMO, extracorporeal mem-
brane oxygenation. *ECMO indication: 1, off CPB; 2, low cardiac output; 3, cardiac
arrest requiring cardiopulmonary resuscitation; 4, other, including respiratory failure,
pulmonary hypertension, and arrhythmias.
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sels, or renal dysfunction. Three patients developed arrhyth-
mias during the cardiac catheterization procedure. One
patient developed complete heart block that was managed
initially with a temporary pacemaker followed by perma-
nent pacemaker placement, another patient developed atrial
tachycardia that responded to adenosine in the cardiac cath-
eterization laboratory, and the third patient developed sinus
bradycardia that terminated after manipulation with the
catheters ceased.
There were no significant outcome differences among pa-
tients undergoing cardiac catheterization or surgical interven-
tion in our study population of early and late diagnosis of
residual lesions. Four patients diagnosed early underwent
cardiac catheterization intervention, and all of them were
decannulated and survived to hospital discharge. Eleven pa-
tients diagnosed earlier had surgical intervention and 8
patients were decannulated, and 5 of them survived to hospi-
tal discharge. Three patients diagnosed later had cardiac cath-
eterization intervention and 1 patient was decannulated
successfully and survived to hospital discharge. Nine patients
diagnosed later had surgical intervention and 3 of them were
decannulated and 1 patient survived to hospital discharge.
The demographics, complexity of cardiac defect, and car-
diac surgery and ECMO details of 35 patients with residualThe Journal of Thoracic and Calesions and 84 patients not suspected of having residual le-
sions are shown in Table 4. A greater number of residual
lesions was detected in patients placed on ECMO for post-
operative low cardiac output status with elevated serum lac-
tate levels and high inotrope and/or high ventilator support.
Twelve of 35 patients (34%) placed on ECMO for low car-
diac output status versus 13 of 84 patients (15%) placed on
ECMO for a similar indication were detected to have resid-
ual lesions (P ¼ .03).
The normalized description of our study population of 35
patients with residual lesions and 84 patients without resid-
ual lesions is shown in Figure 1. Based on ECMO support
duration, 24 patients were detected as having residual le-
sions during the first 3 days of ECMO (early detection,
group A in Figure 1), and 11 patients were detected as hav-
ing residual lesions after 3 days of ECMO (late detection,
group B in Figure 1). Demographic and ECMO details ofrdiovascular Surgery c Volume 147, Number 1 437
FIGURE 1. Outcome of postoperative pediatric cardiac surgery patients
placed on extracorporeal membrane oxygenation (ECMO). In group A,
early detection (3 days of ECMO duration) of residual lesions in postop-
erative pediatric cardiac surgery patients placed on ECMO is noted. In
group B, late detection (>3 days of ECMO duration) of residual lesions
in postoperative pediatric cardiac surgery patients placed on ECMO is
noted. Patients not suspected of having residual lesions are indicated in
group C.
TABLE 5. Comparison between patients detected to have residual
lesions early (3 days on ECMO) and late (>3 days on ECMO)
Details
Early detection
of residual
lesions (n ¼ 24)
Late detection
of residual
lesion (n ¼ 11)
P
value
Age, days; mean (IQR) 13 (6.7-45) 8 (5-45.5) .41
Weight, kg; mean (IQR) 3.3 (2.7-4.2) 3.3 (2.6-4.1) .99
Ventricle physiology, n (%)
One 16 (67) 4 (36) .14
Two 8 (33) 7 (64) .14
CPB, min; mean (IQR) 175.5 (128-239) 232 (196-319) .08
Xct, min; mean (IQR) 45.5 (17-59) 88 (64.5-112) .007
ECMO indication, n (%)*
1 6 (25) 5 (45) .26
2 8 (33) 4 (37) 1.0
3 7 (29) 2 (18) .69
4 3 (13) 0 (0) .54
Surgery-ECMO interval,
days; mean (IQR)
0 (0-1) 0 (0-0) .39
ECMO duration, days;
mean (IQR)
5 (3-7.3) 12 (8.5-13.5) <.001
Decannulation, n (%) 21 (87) 4 (36) .004
Hospital discharge, n (%) 14 (58) 2 (18) .035
IQR, Interquartile range; CPB, cardiopulmonary bypass; Xct, crossclamp time;
ECMO, extracorporeal membrane oxygenation. *ECMO indication: 1, off CPB;
2, low cardiac output; 3, cardiac arrest requiring cardiopulmonary resuscitation;
4, other, including respiratory failure, pulmonary hypertension, and arrhythmias.
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Patients in whom residual lesions were detected later had
longer cardiopulmonary bypass times (P ¼ .08) and signif-
icantly longer crossclamp times (P ¼ .007). We found that
earlier detection of residual lesions was associated with sig-
nificant improvement in successful decannulation from
ECMO (P¼ .004) and greater survival to hospital discharge
(P ¼ .035) compared with later detection (Table 5).DISCUSSION
In our study, we found an incidence of 28% for hemody-
namically significant residual lesions requiring reoperation
or reintervention in postoperative pediatric cardiac surgery
patients receiving ECMO support. Patients placed on
ECMO support for postoperative low cardiac output status
had a greater incidence of detection of residual lesions. Ear-
lier detection of residual lesions within the first 3 days of
ECMO followed by intervention improved significantly
the rate of decannulation and survival to hospital discharge
compared with later detection.
There has been a marked increase in ECMO use for car-
diac support in children after surgical repair of congenital
heart defects.2 The decision to place a child on ECMO is de-
termined by the surgical and medical teams’ judgment, and
is affected by many factors, including ventricular function,
magnitude of conventional inotropic support, and438 The Journal of Thoracic and Cardiovascular Surgpulmonary function. The mortality rate remains high for pa-
tients supported with ECMO primarily for cardiac or hemo-
dynamic failure, when compared with patients supported
with ECMO primarily for respiratory failure.2 The high
mortality in these patients is multifactorial and includes
prolonged mechanical ventilation or cardiopulmonary re-
suscitation prior to initiation of ECMO, prolonged ECMO
support, and ECMO-related complications or organ dys-
function.12-14 There are limited reports in literature that
have evaluated residual lesions and their role in affecting
outcomes in these patients.5,9
Our study revealed residual lesions in 28% of postoper-
ative patients placed on cardiac ECMOwithin 7 days of car-
diac surgery. Kulik and colleagues,6 in their initial study,
detected residual lesions in 22% of postoperative patients
placed on ECMO. They subsequently reported residual le-
sions in 6% of postoperative patients.7 However, they did
not place any postoperative patients requiring E-CPR on
ECMO—an indication for ECMO placement that has in-
creased steadily over a period of time.15 Chaturvedi and col-
leagues16 reported residual lesions in 15% of postoperative
patients placed on ECMO. Their population included only
patients with 2-ventricle physiology. In our study, we found
a significantly greater incidence of residual lesions in pa-
tients placed on ECMO support for postoperative low car-
diac output status. It is possible that, although these
patients separated from cardiopulmonary bypass, they
eventually developed severe myocardial dysfunction inery c January 2014
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lesions, which caused low cardiac output status and the
need for ECMO support. In our population, patients who
were later detected as having residual lesions had longer
cardiopulmonary bypass times and significantly longer
crossclamp times. We believe that the delay in detection
of residual lesions in these patients is a result of an inherent
tendency to allow greater time for myocardial recovery in
patients with longer surgical time periods before any evalu-
ation is undertaken.
The presence of residual lesions after pediatric cardiac
surgery increases the composite morbidity-mortality out-
come.17 The mortality rate is very high in pediatric patients
with residual lesions receiving ECMO support after cardiac
surgery in the absence of reoperation.9 Our study findings of
46% survival to hospital discharge in patients with residual
lesions on ECMO support is in agreement with previously
reported studies.5,15 Booth and colleagues5 reported 48%
survival to hospital discharge after intervention for pediatric
patients with cardiac illness placed on ECMO, and Kane
and colleagues15 reported 54% survival to hospital dis-
charge for pediatric patients with cardiac illness placed on
ECMO for E-CPR. The study population in both these re-
ports, however, included a substantial number of children
with cardiac dysfunction who did not undergo cardiac
surgery.
Because multiple studies have reported that longer dura-
tion of ECMO is associated with increased mortality after
cardiac surgery,6,18,19 we evaluated residual lesions based
on duration of ECMO support. Hintz and colleagues18 re-
ported ECMO duration of<3 days to be associated signif-
icantly with improved survival in neonates placed on
cardiac ECMO. They also reported a longer duration of
ECMO to be the only risk factor associated with increased
mortality in hypoplastic left heart syndrome patients
placed on ECMO.18 Aharon and colleagues19 also reported
significantly increased mortality in postoperative cardiac
surgery patients placed on ECMO for>3 days. A longer
duration of ECMO support exposes the patient to increased
risks of complications, including neurologic, cardiac,
renal, and pulmonary damage responsible for increased
mortality. We found a significant improvement in decannu-
lation and survival to hospital discharge in patients diag-
nosed with residual lesions during the first 3 days of
ECMO support compared with later diagnosis and inter-
vention. The primary goal of ECMO support during the
postoperative period is to maintain tissue perfusion during
myocardial recovery. Reversibility of heart dysfunction is
a key determinant to successful decannulation of ECMO
that may be impaired in the presence of residual lesions.
In our population, earlier detection and intervention for re-
sidual lesions may have facilitated myocardial recovery,
leading to a greater rate of successful decannulation and
survival.The Journal of Thoracic and CaThe detection of residual lesions requires high-quality
imaging studies. Transthoracic echocardiography identified
20% of the residual lesions in our study. Our results corrob-
orate those of another study that reported 4 of the 21 resid-
ual lesions (19%) detected correctly by transthoracic
echocardiography for patients on ECMO.5 Transthoracic
echocardiography is an easy-to-perform bedside imaging
study for patients on ECMO and has assessed ECMO can-
nula positions successfully.20 However, there are several
limitations for application and use of transthoracic echocar-
diography for assessment of residual lesions on ECMO. The
changes in preload on venoarterial ECMO affect assessment
of ventricular ejection fraction by echocardiography.21 Pa-
tients with left-to-right shunting have fractional shortening
of<10% during the course of cardiac ECMO.22 Evaluation
of ejection fraction by echocardiography on ECMO has
been reported to be similar between nonsurvivors and survi-
vors after 1 month of ECMO decannulation.23 The majority
of residual lesions in our study were detected in pulmonary
arteries, aortas, or shunts. The residual lesions seen com-
monly after congenital heart surgery including residual
shunts, obstructed ventricular outflow pathways, and atrio-
ventricular valve regurgitation are not detected easily by
transthoracic echocardiography.24,25 Air in the chest,
bandages, open sternum, endotracheal tube and ventilator
tube, pacing wires, chest tubes, and many others lead to
poor acoustic windows and limit access to standard views
on transthoracic echocardiography. Lack of good-quality
suprasternal and parasternal views limit detailed imaging
of the aorta, superior vena cava, left ventricle outflow tract
(subvalvar, valvar, and supravalvar portions) as well as wall
motion abnormalities. The use of alternative noninvasive
imaging studies including transesophageal echocardiogra-
phy on ECMO is limited by probe size in small neonates,
concern for upper gastrointestinal bleeding related to coa-
gulopathy, and lack of reliability in assessing residual
lesions in left ventricular outflow tracts, right ventricular
outflow tracts, left pulmonary artery, and apical interven-
tricular septum.26
Cardiac catheterization has long served as the gold stan-
dard for the anatomic and physiologic assessment of patients
with congenital heart disease. There is, however, clinical re-
luctance toward performing invasive investigation and possi-
ble transcatheter interventions in patients during the early
postoperative period.27 Ettedgui and colleagues28 and des
Jardines and colleagues29 first described the feasibility of
cardiac catheterization on patients supported by ECMO.
Subsequently, Booth and colleagues5 reported the safety of
cardiac catheterization in pediatric patients supported on
cardiac ECMO.Cardiac catheterization revealed unexpected
diagnostic information of clinical importance in 91% of our
patients who underwent this imaging study on ECMO. The
new findings on cardiac catheterization imaging were not
suspected on bedside imaging in all patients, and the bedsiderdiovascular Surgery c Volume 147, Number 1 439
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location, or significance of pathologic lesions. In the study
by des Jardines and colleagus,26 clinicalmanagementwas al-
tered significantly in 73% of the 15 patients on ECMO who
underwent a cardiac catheterization study. Cardiac catheter-
ization may be helpful not only for diagnostic purposes, but
also for therapeutic interventions for patients on ECMO.
Seven of the 27 residual lesions were managed by catheter
intervention in our study without any major complications.
In the study by Zahn and colleagues,30 5 of 9 postoperative
patients underwent catheter intervention on ECMO. Simi-
larly, in the study by Booth and colleagues,5 12 of the 21
postoperative patients on ECMO underwent catheter inter-
vention. Our findings are in agreement with recent recom-
mendations by the American Heart Association that
advocate cardiac catheterization with the potential for inter-
vention early during the postoperative period in critically ill
patients onECMOwhen there is a high index of suspicion for
the presence of a residual structural lesion or lesions and
noninvasive diagnostics fail to identify a cause for hemody-
namic and/or clinical compromise (class 1, level B).31
Our study has limitations inherent to any retrospective
analysis of a single center’s experience. The relatively small
sample size limited our ability to analyze outcomes based
on surgical diagnosis and precluded regression tests to iden-
tify independent predictors. In addition, there may be unac-
counted confounders that may explain outcome differences
between patients with and without residual lesions, and dif-
ferences in clinical outcomes based on the timing of lesion
detection. The timing of the echocardiograms performed in
our study was not uniform between patients and may not
have been performed using standardized ECMO flows dur-
ing the weaning process. Improvised echocardiographic
imaging techniques and perisurgical imaging studies in a hy-
brid operating suite may facilitate earlier identification of
residual lesions in the future. A direct pressure measure-
ment with a needle during the ECMO weaning trial may
have facilitated detection of pressure overload in the corre-
sponding ventricle in suspected patients. Although helpful,
it remains inconclusive in specifying the type, location, or
significance of pressure overload. In our retrospective study
analysis, 43 patients were evaluated by echocardiography
and/or cardiac catheterization for residual lesions because
they were unable to be weaned successfully from ECMO.
Fifty-nine of the remaining 76 patients underwent echocar-
diography and 1 patient underwent cardiac catheterization
on ECMO that did not reveal any residual lesions. More im-
portant, it is possible that, in 51 of the 84 patients who died
before discharge, cardiac catheterization may have detected
residual lesions had this been pursued despite clinical judg-
ment and echocardiographic results. Last, we were unable
to differentiate whether increased mortality in later detec-
tion of residual lesions was secondary to lack of complete
myocardial recovery despite intervention or a result of440 The Journal of Thoracic and Cardiovascular Surgprolonged duration of ECMO and its related complications.
Detailed autopsy studies may have helped to delineate
cause of death.
Despite the study limitations,we conclude that assessment
of adequacy of surgical repair and the primary reason for
ECMO support should begin soon after patient stabilization.
Extracorporeal membrane oxygenation decannulation
should not be attempted unless identification by cardiac im-
aging studies and repair of the residual lesion that is expected
to have a hemodynamic impact on myocardial recovery take
place. Echocardiography remains a powerful imaging tool;
however, we must recognize its limitations during ECMO
and proceed with cardiac catheterization expediently in
cases in which echocardiography alone does not explain he-
modynamic compromise. Early assessment and intervention
for residual lesions in postoperative cardiac surgery patients
receiving ECMO support improves their outcome.References
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